The best indicator for Corteva (CTVA)
We backtested 366 indicators across daily, weekly and hourly charts on real Corteva (CTVA) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the daily chart, this is the strongest risk-adjusted edge we found for Corteva (CTVA) over ~7.0 years — beating buy-and-hold by 6.8% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Corteva (CTVA) — trailing buy-and-hold by 1.9% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Daily | 23.2% | 0.99 | -28.2% | 75.9% | 29 | 6.8% |
| 2 | CCI ✓ | Daily | 19.5% | 0.94 | -28.2% | 80.0% | 40 | 3.1% |
| 3 | SMC: Liquidity Sweep ✓ | Daily | 20.9% | 0.94 | -31.7% | 80.0% | 25 | 4.5% |
| 4 | Williams %R ✓ | Daily | 19.9% | 0.92 | -28.2% | 70.0% | 50 | 3.5% |
| 5 | DeMarker ✓ | Daily | 18.6% | 0.9 | -29.9% | 82.1% | 28 | 2.2% |
| 6 | MA Envelope ✓ | Daily | 17.8% | 0.88 | -28.2% | 72.7% | 55 | 1.4% |
| 7 | Connors RSI-2 ✓ | Weekly | 12.7% | 0.83 | -11.7% | 87.5% | 16 | -3.5% |
| 8 | Camarilla Pivots ✓ | Weekly | 13.5% | 0.81 | -16.9% | 60.3% | 78 | -2.7% |
| 9 | MA Envelope ✓ | Weekly | 14.9% | 0.79 | -24.9% | 88.2% | 17 | -1.4% |
| 10 | Demand Index ✓ | Weekly | 15.7% | 0.79 | -29.5% | 76.2% | 21 | -0.5% |
| 11 | Projection Bands ✓ | Daily | 13.3% | 0.74 | -20.0% | 71.0% | 62 | -3.1% |
| 12 | QQE ✓ | Weekly | 15.9% | 0.74 | -38.1% | 52.9% | 17 | -0.4% |
| 13 | Bollinger Mean-Reversion ✓ | Daily | 12.9% | 0.73 | -28.2% | 73.3% | 30 | -3.5% |
| 14 | Fibonacci Bands ✓ | Daily | 12.9% | 0.73 | -28.2% | 73.3% | 30 | -3.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Corteva (CTVA), WaveTrend (8/6/4) on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.